Human Milk Oligosaccharides (HMO) is a complex bioactive sugar molecule present in human milk. It functions as growth substrates for particular beneficial bacteria. Due to being structurally complex and diverse, extracting or synthesizing them for use in the formula is challenging. As human milk oligosaccharides (HMO) is beneficial for microbiome and immunity, therefore, many new techniques are getting researched and developed by the key player which include extracting HMO from cow milk, practicing expensive techniques (chemically or enzymatically synthesizing) or using microbes to produce them. Human Milk Oligosaccharides (HMO) products are expensive because a large amount of human milk is to be synthesized to achieve a handful of HMO. Hence as a remedy extracting and synthesizing techniques are improving.

Human Milk Oligosaccharides (HMO) Market: Market Dynamics and Restraints

The human milk oligosaccharides (HMO) market is expected to experience investments over the forecast period; the key factors that lift the market growth include the increase in application scope in infant formula and functional beverages, rapid technological advancement in the product line, rising awareness of health and increasing dairy industry.  The shift in lifestyles focusing towards nutritious food is likely to lift product need. Among all applications, use in infant formula registers significant share in terms of volume for this market; this is because of the concerns related to child malnourishment and mortality all over the globe. Human milk oligosaccharides (HMO) abide prebiotic properties, ability to enhance memory & brain development as well as high nutritional content, these quality propel market demand of human milk oligosaccharides (HMO).

Although demand and necessity of Human Milk Oligosaccharides (HMO) in the market can be seen broadly, many manufacturers such as Inbiose and others uses methods such as fermentation technologies, chemical and enzymatic synthesis, etc., for manufacturing human milk oligosaccharides. Among methods mentioned above chemical and enzymatic synthesis method are costly and have low raw material availability, thus restraining the market.

Human Milk Oligosaccharides (HMO) Market: Market Segmentation    

The global Human Milk Oligosaccharides (HMO) market is segmented into two parts based on its types and applications.

Based on its types the global human milk oligosaccharides (HMO) market is segmented into:

  • 2’FL
  • 3’FL
  • 3’SL
  • 6’SL

Based on the applications the global human milk oligosaccharides (HMO) market is segmented into:

  • Infant formulas
  • Health ingredients for human and animal
  • Food & beverages
  • Food supplements

Human Milk Oligosaccharides (HMO) Market: Regional Outlook 

Regarding geography, the human milk oligosaccharides market has been categorized into seven key regions including North America, Latin America, Eastern Europe, Western Europe, Asia-Pacific excluding Japan, Japan, and the Middle East & Africa. The human milk oligosaccharides market is expected to register healthy CAGR during the forecast period. Due to a large number of manufacturers as well as growing demand for infant formulas in countries such as Germany, France, Italy, U.K and Spain together with the considerable growth of dairy products demand in  UK and Germany made Eastern and Western Europe leading region in human milk oligosaccharides (HMO) market. In developing countries such as China, India, and South Korea growth in the health concerns vis-à-vis chronic diseases like high blood pressure, diabetes, and rickets and above all, rising demand for nutritional supplements from China and India is expected to witness highest growth rate in the human milk oligosaccharides market. Whereas, North and Latin America are experiencing steady growth.

Human Milk Oligosaccharides (HMO) Market: Key players 

Human Milk Oligosaccharides (HMO) market has a limited number of the manufacturer, this led to high competitive conflict among companies, and some of the key players in this market are Elicityl SA, Medolac Laboratories, Inbiose, Glycosyn, ZuChem, Jennewein Biotechnologie, and Glycom. Human Milk Oligosaccharides (HMO) market is competitive, to keep their product updated and in demand, extensive research and development are practiced by the key players to come up with the cost effective technology product line, therefore due to technological advancement coupled with  reduction in prices, the market is hindering entry of new entrance.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Human Milk Oligosaccharides Market

Pre Book